ARS Pharmaceuticals

ARS Pharmaceuticals (operating at ars-pharma.com) is a biopharmaceutical company engineered for developing patient-friendly treatments to address serious issues related to needle-related risks, device portability and severe allergic reactions. Founded in 2015 and headquartered in San Diego, California, ARS Pharmaceuticals develops and commercializes treatments for severe allergic reactions in the United States. Under the hood, the company leverages its expertise in biopharmaceuticals to create innovative needle-free solutions. This allows patients and their caregivers to access life-saving treatments with greater ease and convenience. Backed by $75M in funding over 2 rounds.